In this model, while the disease-causing mutation was identified, PDE6C mutations only account for 1% of clinical cases of achromatopsia in humans [28], with CNGB3 and CNGA3 accounting for the majority of cases. The gene discussed is PDE6C; the disease is achromatopsia.